You have 9 free searches left this month | to do more

bortezomib

Bortezomib is a drug used to treat Multiple Myeloma, Lymphoma, Mantle Cell Lymphoma, and other conditions. Bortezomib is being actively studied in 122 studies and prior, has been studied in 317.

Top SponsorsTop SitesTop Investigators
National Cancer Institute (NCI)Mayo ClinicIrene Ghobrial, MD
Dana-Farber Cancer InstituteDana-Farber Cancer InstitutePaul G. Richardson, MD
M.D. Anderson Cancer CenterWashington University School of MedicineE. Steve Woodle
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Active, not recruiting
  • Lymphoma, Mantle Cell
  • Mantle Cell Lymphoma
  • Rituximab (R)
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2021-09-21
Sep 21, 2021
E
Active, not recruiting
  • Multiple Myeloma
  • Rionero in Vulture, Potenza, Italy
    Irccs Crob
2021-02-04
Feb 4, 2021
N
Completed
  • Lung Diseases, Interstitial
  • +2 more
  • Bortezomib
  • +2 more
  • Chicago, Illinois
    Northwestern University
2021-08-02
Aug 2, 2021
S
Recruiting
  • Antibody-mediated Rejection
  • Bortezomib
  • Tehran, Iran, Islamic Republic of
    SBMU
2020-12-30
Dec 30, 2020
P
Recruiting
  • Amyloidosis; Systemic
  • Beijing, China
    Peking Union Medical College Hospital
2021-05-31
May 31, 2021
M
Recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Bortezomib
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
2021-10-06
Oct 6, 2021
H
Not yet recruiting
  • Acute Lymphoblastic Leukemia, in Relapse
  • +2 more
  • Bortezomib
  • Mexico City, Mexico
    Hospital General de México "Dr. Eduardo Liceaga"
2021-11-16
Nov 16, 2021
E
Completed
  • Multiple Myeloma
  • Bortezomib
  • +3 more
  • Atlanta, Georgia
    Emory University Winship Cancer Institute
2021-11-01
Nov 1, 2021
H
Recruiting
  • Hematological Malignancy
  • Bortezomib
  • Detroit, Michigan
    Henry Ford hospital
2020-11-03
Nov 3, 2020
D
Terminated
  • Waldenstrom's Macroglobulinemia
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
2021-04-22
Apr 22, 2021
J
Completed
  • Acute Myelogenous Leukemia
  • Sacramento, California
    University of California Comprehensive Cancer Center
2021-02-04
Feb 4, 2021
A
Completed
  • Chronic Antibody-mediated Transplant Rejection
  • Bortezomib
  • Plasma exchanges and intravenous immunoglobulins
  • Paris, France
    Hopital Necker Enfants-malades
2020-09-14
Sep 14, 2020
U
Recruiting
  • Hodgkin's Lymphoma
  • Lymphoma, Non-Hodgkin
  • Ann Arbor, Michigan
    University of Michgan Comprehensive Cancer Center
2021-02-10
Feb 10, 2021
S
Active, not recruiting
  • Diffuse Large B Cell Lymphoma
  • Bortezomib
  • Seoul, Korea, Republic of
    Samsung Medical Center
2020-10-21
Oct 21, 2020
N
Completed
  • Chronic Myeloid Leukemia (CML)
  • +4 more
  • Bortezomib
  • NK cells
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2021-11-11
Nov 11, 2021
D
Completed
  • Waldenstrom's Macroglobulinemia
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
2020-10-06
Oct 6, 2020
J
Completed
  • Kidney Cancer
  • bortezomib
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center at UCLA
2020-08-17
Aug 17, 2020
B
Completed
  • Amyloidosis
  • Bortezomib
  • +2 more
  • Boston, Massachusetts
    Boston Medical Center
2020-09-04
Sep 4, 2020
M
Active, not recruiting
  • Solid Tumor
  • Urethral Cancer
  • Bortezomib
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2020-12-01
Dec 1, 2020